Tags: Drug.

Eplivanserin (SR-46349; planned trade name Ciltyri) was an experimental drug for the treatment of insomnia which was being developed by Sanofi Aventis.Sanofi Aventis announced in December 2009 that it was withdrawing its application for approval of eplivanserin from both the U.S. Food and Drug Administration and the European Medicines Agency.

Eplivanserin_structure.svg
ATC prefix
none
CAS number
130579-75-8
CAS supplemental
(fumarate)
FDA UNII code
3CO94WO6DJ
IUPAC name
(ZE)-1-(2-fluorophenyl)-3-(4-hydroxyphenyl)-2-propen-1-one O-[2-(dimethylamino)ethyl]oxime
PubChem
5493160

Loading...

This page contains content from the copyrighted Wikipedia article "Eplivanserin"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.